| Literature DB >> 26411462 |
Marleen R van Walsem1,2, Emilie I Howe3,4, Kristin Iversen5, Jan C Frich6,7, Nada Andelic8,9.
Abstract
BACKGROUND: In order to plan and improve provision of comprehensive care in Huntington's disease (HD), it is critical to understand the gaps in healthcare and social support services provided to HD patients. Research has described utilization of healthcare services in HD in Europe, however, studies systematically examining needs for healthcare services and social support are lacking. This study aims to identify the level and type of met and unmet needs for health and social care services among patients with HD, and explore associated clinical and socio-demographic factors.Entities:
Mesh:
Year: 2015 PMID: 26411462 PMCID: PMC4585992 DOI: 10.1186/s13023-015-0324-8
Source DB: PubMed Journal: Orphanet J Rare Dis ISSN: 1750-1172 Impact factor: 4.123
Fig. 1Flow chart illustrating patient recruitment process
Socio-demographic statistics for complete sample and divided across V disease stages
| Complete sample ( | Stage I ( | Stage II ( | Stage III ( | Stage IV ( | Stage V ( | |||
|---|---|---|---|---|---|---|---|---|
| Variables | Categories | Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | Sign |
| Agea | 58 (15) | 49 (20) | 54 (21) | 58 (11) | 58 (8) | 59 (16) | 0.104 | |
| Education (years/)b | 12 (5) | 13 (5) | 12 (7) | 11 (2) | 12 (6) | 11 (6) | 0.168 | |
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) |
| ||
| Gender | Female | 39 (45) | 5 (42) | 9 (39) | 7 (37) | 8 (53) | 10 (59) | 0.625 |
| Male | 47 (55) | 7 (58) | 14 (61) | 12 (63) | 7 (47) | 7 (41) | ||
| Education | Lower | 52 (60.5) | 5 (42) | 12 (52) | 15 (79) | 9 (60) | 11 (65) | 0.424 |
| Higher | 34 (39.5) | 7 (58) | 11 (48) | 4 (21) | 6 (40) | 6 (35) | ||
| Sivil status | Single | 36 (42) | 4 (33) | 7 (30) | 9 (47) | 8 (53) | 8 (47) | 0.587 |
| Married | 50 (58) | 8 (67) | 16 (70) | 10 (53) | 7 (47) | 9 (53) | ||
| Occupationc | Manual | 41 (48) | 5 (42) | 10 (43.5) | 12 (63) | 6 (40) | 8 (47) | 0.666 |
| Non-manual | 42 (49) | 7 (58) | 13 (56.5) | 7 (37) | 8 (53) | 7 (41) | ||
| Occupational status | Employed | 14 (16) | 11 (92) | 3 (13) | 0 (0) | 0 (0) | 0 (0) | 0.001 |
| Unemployed | 72 (84) | 1 (8) | 20 (87) | 19 (100) | 15 (100) | 17 (100) | ||
| Informant | Patient | 27 (31) | 9 (75) | 14 (61) | 4 (21) | 0 (0) | 0 (0) | 0.001 |
| Patient & informant/informant only | 59 (69) | 3 (25) | 9 (39) | 15 (79) | 15 (100) | 17 (100) | ||
| Housing situation | Living at home | 54 (63) | 12 (100) | 23 (100) | 13 (68) | 6 (40) | 0 (0) | 0.001 |
| Not living at home | 32 (37) | 0 (0) | 0 (0) | 6 (32) | 9 (60) | 17 (100) | ||
| Residence | Rural | 13 (15) | 1 (8) | 4 (17) | 2 (10.5) | 3 (20) | 3 (18) | 0.878 |
| Urban | 73 (85) | 11 (92) | 19 (83) | 17 (89.5) | 12 (80) | 14 (82) |
IQR Interquartile range; Group comparison across the five disease stages performed using Chi-square tests for independent samples (categorical values). anormally distributed and therefore reported result from ANOVA). bnot normally distributed therefore performed and reported Kruskal-Wallis test. c3 responses missing (1 in stage IV and 2 in stage V). Remaining proportions and comparisons are crosstabs / Chi-square. IQR: Interquartile range
Sample clinical characteristics
| Complete sample ( | Stage I ( | Stage II ( | Stage III ( | Stage IV ( | Stage V ( | |||
|---|---|---|---|---|---|---|---|---|
| Variables | Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | Sign | |
| Disease duration | 6 (7) | 2 (2) | 5 (6) | 7 (5) | 8 (7) | 10 (8) |
| |
| Total FAS score | 15 (17) | 24 (2) | 20 (2) | 15 (4) | 5 (2) | 0 (3) |
| |
| Independence score | 70 (35) | 97 (9) | 80 (5) | 65 (10) | 45 (20) | 20 (6) |
| |
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) |
| ||
| Comorbid conditions | 0.157 | |||||||
| None | 50 (58) | 7 (8) | 10 (12) | 9 (10) | 11 (13) | 13 (15) | ||
| Neurological | 1 (1.2) | 1 (1.2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||
| Heart and vessels | 8 (9.3) | 2 (2.3) | 2 (2.3) | 2 (2.3) | 2 (2.3) | 0 (0) | ||
| Lung | 2 (2.3) | 0 (0) | 0 (0) | 2 (2.3) | 0 (0) | 0 (0) | ||
| Cancer | 4 (4.8) | 0 (0) | 1 (1.2) | 1 (1.2) | 1 (1.2) | 1 (1.2) | ||
| Muskulosceletal | 5 (5.8) | 0 (0) | 3 (3.5) | 2 (2.3) | 0 (0) | 0 (0) | ||
| Other | 9 (10.5) | 2 (2.3) | 2 (2.3) | 2 (2.3) | 0 | 3 (3.5) | ||
| Multiple | 7 (8.1) | 0 (0) | 5 (5.8) | 1 (1.2) | 1 (1.2) | 0 (0) |
FAS Functional Assessment Scale, IQR Interquartile range; Group comparisons are completed using Chi-square tests for categorical variables and Kruskall-Wallis for continuous/interval variables, as none of the continuous variables were normally distributed
Fig. 2Bargraphs illustrating level of needs, provision and unmet needs for NPCS total, domain and subscale scores
Proportions of unmet needs among participants
| Complete sample ( | Stage I ( | Stage II ( | Stage III ( | Stage IV ( | Stage V ( | ||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) |
| ||
| NPCSa total score | Met needs | 6 (7) | 1 (8) | 2 (9) | 0 (0) | 1 (7) | 2 (12) | 0.723* | |
| Unmet needs | 79 (92) | 11 (92) | 21 (91) | 18 (95) | 14 (93) | 15 (88) | |||
| Domain score Health and Personal care | Met needs | 15 (17) | 3 (25) | 5 (22) | 1 (5) | 2 (13) | 4 (23.5) | 0.502* | |
| Unmet needs | 71 (83) | 9 (75) | 18 (78) | 18 (95) | 13 (87) | 13 (76.5) | |||
| Subscale | Healthcare | Met needs | 59 (69) | 10 (83) | 18 (78) | 11 (58) | 9 (60) | 11 (65) | 0.426* |
| Unmet needs | 27 (31) | 2 (17) | 5 (22) | 8 (42) | 6 (40) | 6 (35) | |||
| Personal Care | Met needs | 35 (52) | 12 (100) | 16 (70) | 5 (26) | 5 (33) | 7 (41) | 0.001 | |
| Unmet needs | 41 (48) | 0 (0) | 7 (30) | 14 (74) | 10 (67) | 10 (59) | |||
| Rehabilitation | Met needs | 22 (26) | 4 (33) | 6 (26) | 1 (5) | 6 (40) | 5 (29) | 0.180* | |
| Unmet needs | 64 (74) | 8 (67) | 17 (74) | 18 (95) | 9 (60) | 12 (71) | |||
| Domaina score Social Care and Support | Met needs | 17 (20) | 5 (42) | 4 (17) | 0 (0) | 4 (27) | 4 (23.5) | 0.070* | |
| Unmet needs | 68 (79) | 7 (58) | 19 (83) | 18 (95) | 11 (73) | 13 (76.5) | |||
| Subscale | Social and family supporta | Met needs | 28 (33) | 6 (50) | 6 (26) | 2 (10.5) | 6 (40) | 8 (47) | 0.098* |
| Unmet needs | 57 (66) | 6 (50) | 17 (74) | 16 (84) | 9 (60) | 9 (63) | |||
| Specialist equipment | Met needs | 45 (52) | 8 (67) | 13 (56.5) | 6 (32) | 9 (60) | 9 (53) | 0.310 | |
| Unmet needs | 41 (48) | 4 (33) | 10 (43.5) | 13 (68) | 6 (40) | 8 (47) | |||
| Accommodation | Met needs | 59 (69) | 12 (100) | 20 (87) | 12 (63) | 8 (53) | 7 (41) | 0.002* | |
| Unmet needs | 27 (31) | 0 (0) | 3 (13) | 7 (37) | 7 (47) | 10 (59) |
NPCS Needs and Provision Complexity Scale; Chi-square test for categorical variables was used; *Five or less cells have expected count less than five. amissing data (1 missing NPCS total score, disease stage III; 1 missing domain score social care and support, disease stage III; 1 missing subscale social and family support, disease stage III)
Factors associated with level of unmet needs using binary multiple logistic regression models for total level of unmet needs (NPCS total score), level of unmet needs for health and personal care services (NPCS health and personal care score) and for level of unmet needs for social care and support services (NPCS social care and support score)
| NPCS unmet needs: total ( | NPCS unmet needs: domain health and personal care ( | NPCS unmet needs: domain social care and support ( | |
|---|---|---|---|
| Socio-demographic and clinical Variables | Multivariate analysis OR (95 % CI)** | Multivariate analysis OR (95 % CI)*** | Multivariate analysis OR (95 % CI)**** |
| Age | 1.03 (0.98 – 1.08) | 1.02 (0.97 – 1.07) | 1.00 (0.96 – 1.05) |
| Education Level | 0.78 (0.28 – 2.22) | 0.48 (0.16 – 1.45) | 1.40 (0.467 – 3.95) |
| High education vs. lower educationa | |||
| Disease duration | 0.97 (0.86 – 1.10) | 0.98 (0.86 – 1.13) | 1.00 (0.89 – 1.13) |
| Comorbidity | 0.91 (0.31 – 2.70) | 0.83 (0.25 – 2.74) | 0.65 (0.22 – 1.90) |
| Comorbidity vs. no comorbiditya | |||
| HD Phase | 3.57 (0.89 – 14.4)***** | 2.77 (0.62 – 12.36) | 1.06 (0.27 – 4.18) |
| Middle phase vs. early phasea | |||
| HD Phase | 1.38 (0.32 – 6.0) | 2.20 (0.42 – 11.67) | 1.06 (0.24 – 4.75) |
| Advanced phase vs. earlya | |||
| Informant | 0.52 (0.13 – 2.04) | 0.57 (0.14 – 2.30) | 1.03 (0.24 – 3.6) |
| Patient vs. patient with informanta |
aReference group
*OR > 1 increase the Odds of having a high level of unmet needs; OR < 1 decrease the odds of having high level of unmet needs
**Hosmer and Lemeshow Goodness-of-fit test χ 2 9.12; df 8; P = 0.332
***Hosmer and Lemeshow Goodness-of-fit test χ 2 6.63; df 8; P = 0.612
**** Hosmer and Lemeshow Goodness-of-fit test χ 2 6.65; df 8; P = 0.575
*****Approached significance (p = 0.074)